During the past decade or so, technological advancements in the sequencing industry have largely been led by Illumina and brought down the cost of assembling one genome from nearly $3 billion in the ...

Q3 2024 Earnings Call Transcript November 7, 2024 Pacific Biosciences of California, Inc. beats earnings expectations.

Illumina's margin expansion and a coming revenue recovery should help the stock multiples re-rate toward life science ...

Q3 2024 Earnings Conference Call November 4, 2024 4:30 PM ETCorporate ParticipantsSalli Schwartz - Vice President of ...

Another Monday, another fitness lesson from Malaika Arora. The star is an avid fitness lover, and her social media posts are proof. Every Monday, the star posts a new episode of the Monday motivation ...

Besides highlighting its sequencers, the company also launched a program to help researchers who want to incorporate spatial transcriptomic into their research.

Annual Meeting (Nov. 5-9, 2024), Complete Genomics, a pioneering genomic sequencing company, will highlight an expanded application menu and broader market adoption of its flagship sequencer DNBSEQ-T7 ...

Detection Sorter Enables Effective Content Isolation; Opens Door to Scientific DiscoveriesFREMONT, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CTKB) has introduced an Enhanced Small Particle ...

It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and ...

Elevated IL-10 in diabetes causes capillary obstruction, linked to cognitive deficits. Blocking IL-10 receptors shows promise for improving brain function.